Daniel R. Rigsbee
Eli Lilly and Company
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Daniel R. Rigsbee.
Pharmaceutical Research | 1997
Michael J. Pikal; Daniel R. Rigsbee
AbstractPurpose. Generalizations based upon behavior of small molecules have established that a crystalline solid is generally much more stable toward chemical degradation than is the amorphous solid. This study examines the validity of this generalization for proteins using biosynthetic human insulin as the model protein. Methods. Amorphous insulin was prepared by freeze drying the supernate from a suspension of zinc insulin crystals adjusted to pH 7.1. Storage stability at 25°C and 40°C were compared for the freeze dried material, the dried suspended crystals, and the starting batch of crystals. Samples were equilibrated at selected relative humidities between zero and 75% to obtain samples at various water contents. Assays for dimer formation were performed by size exclusion HPLC and assays for deamidated product were carried out by reverse phase HPLC. Degradation was found to be linear in square root of time, and the slopes from % degradation vs. square root of time were used to define the rate constants for degradation. Differential scanning calorimetry (DSC) and Fourier-transform infrared spectroscopy (FTIR) were used to characterize the state of the protein in the solids. Results. As expected based upon previous results, the primary degradation pathways involve deamidation at the AsnA21 site and co-valent dimer formation, presumably involving the A-21 site. Contrary to expectations, amorphous insulin is far more stable than crystalline insulin under all conditions investigated. While increasing water content increases the rate of degradation of crystalline insulin, rate constants for degradation in the amorphous solid are essentially independent of water content up to the maximum water content studied (≈15%). Conclusions. Based upon the FTIR and DSC data, both crystalline and amorphous insulin retain some higher order structure when dried, but the secondary structure is significantly perturbed from that characteristic of the native solution state. However, neither DSC nor FTIR data provide a clear interpretation of the difference in stability between the amorphous and crystalline solids. The mechanism responsible for the superior stability of amorphous insulin remains obscure.
Journal of Pharmaceutical Sciences | 2008
Michael J. Pikal; Daniel R. Rigsbee; Michael L. Roy; Dawn Galreath; Karl J. Kovach; Bingquan Wang; John F. Carpenter; Marcus T. Cicerone
This research presents storage stability of human growth hormone, hGH, in lyophilized di-saccharide formulations. Stability via HPLC assay was assessed at 40 and 50 degrees C. Structure of the protein in the solids was assessed by infrared spectroscopy. Molecular mobility was characterized by structural relaxation times estimated from DSC data and by measurement of atomic motion on a nanosecond time scale by neutron scattering. Very large stability differences were observed among the various formulations, with both chemical and aggregation stability showing the same qualitative trends with formulation. Near the T(g), T(g) appeared to be a relevant stability parameter, but for storage well below T(g), stability seems unrelated to T(g). Stability (chemical and aggregation) was weakly correlated with secondary structure of the protein, and there was a partial quantitative correlation between degradation rate and the structural relaxation time. However, at equivalent levels of disaccharide relative to protein, sucrose systems were about a factor of two more stable than trehalose formulations, but yet had greater mobility as measured by structural relaxation time. Secondary structure was equivalent in both formulations. Neutron scattering results documented greater suppression of fast dynamics by sucrose than by trehalose, suggesting that well below T(g), fast dynamics are important to stability.
Journal of Pharmaceutical Sciences | 2009
Michael J. Pikal; Daniel R. Rigsbee; Michael J. Akers
This research addresses the thermodynamic significance of the denaturation endotherm observed during differential scanning calorimetry (DSC) scans of proteins in dry formulations, such as freeze dried solids. Human growth hormone formulations are the chosen representative examples. We employ observations of denaturation temperature, glass transition temperature, and the differences between estimated molecular mobilities to argue that unfolding is under partial thermodynamic control. Further, unfolding during a DSC scan is simulated using a three state kinetic model, which is a two state unfolding model followed by aggregation. Kramers-type rate constants are used, where the preexponential term is dominated by viscous forces. Simulation results are in qualitative agreement with experiment, and clearly show that while the denaturation endotherm is impacted by irreversibility, caused by nonzero scan rate and aggregation, the position of the endotherm peak is changed only slightly. Thus, the denaturation peak is a good approximation for the thermodynamic denaturation temperature. Using data for denaturation temperature, heat of denaturation, and heat capacity of denaturation, free energy versus temperature curves were calculated. We find that even formulations with added saccharides are thermodynamically unstable near ambient temperature; significant denaturation in the solid state is prevented by low mobility.
Journal of Pharmaceutical Sciences | 2002
Jinsong Liu; Daniel R. Rigsbee; Carol Stotz; Michael J. Pikal
Journal of Pharmaceutical Sciences | 1998
Gregory A. Stephenson; Edward G. Groleau; Rita L. Kleemann; Wei Xu; Daniel R. Rigsbee
Journal of Pharmaceutical Sciences | 1998
Lian Yu; Dinesh Mishra; Daniel R. Rigsbee
Macromolecules | 1993
Jiulin Xia; Huiwen Zhang; Daniel R. Rigsbee; Paul L. Dubin; Tehseen Shaikh
Macromolecules | 1988
Paul L. Dubin; Daniel R. Rigsbee; Leong-Ming Gan; M. A. Fallon
Journal of Pharmaceutical Sciences | 2007
Michael J. Pikal; Daniel R. Rigsbee; Michael L. Roy
Thermochimica Acta | 2006
Liuquan (Lucy) Chang; Nathaniel Milton; Daniel R. Rigsbee; Dinesh Mishra; Xiaolin (Charlie) Tang; Leonard C. Thomas; Michael J. Pikal